p.s. In my prior reply, I forgot to say that your post is not the quiz answer. The quiz answer has to do with the design of the phase-3b trial per se, not to some aspect of the overall Telaprevir program.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”